Skip to content
Recall Observatory FDA recall evidence

Drug product

Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.

D-0393-2025

April 09, 2025

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 96637
Status
Ongoing
Classification
Class II
Quantity
48 Cartons
Official record key
drug-enforcement:D-0393-2025

Official wording

Reason: Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Code information: Lot PZFDE06, Exp 08/31/2025

Distribution pattern: NC, SC, VA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.